Anthem: Cigna helped kill $49B merger by dragging feet

Cigna cut Anthem “off at the knees” in its effort to assuage antitrust concerns over a proposed $48.9 billion merger, Anthem’s general counsel said during trial, according to Bloomberg.

Advertisement

Anthem’s top lawyer, Thomas Zielinski, told a judge Feb. 25 that Cigna officials intentionally dragged their feet on the merger. Among several accusations, he said that Cigna refused to consider spinning off some of its assets that would have helped the transaction gain regulatory approval.

In addition, Mr. Zielinski said once Cigna CEO David Cordani found out he wouldn’t get the role he wanted within the new company, Cigna stopped cooperating and did not hand over data Anthem needed to present efficiencies of the merger to Justice Department officials.

A trial over whether Anthem or Cigna owes the other billions after the botched merger attempt began Feb. 25. While Cigna argues it’s owed more than $16 billion as the injured party, Anthem claims it’s owed $20 billion because Cigna sabotaged the deal.

For the full Bloomberg report, click here.

More articles on payers:
Cigna eyes expansion in China: 3 things to know
Wyoming’s Medicaid work requirement moves forward
Group Health Cooperative of South Central Wisconsin names CNO: 3 points

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Transactions & Valuation Issues

Advertisement

Comments are closed.